Showing results (71-80 of 327) with videos related to
Sort By:
Pageof 33
Expert Opinion on Drug Safety|July 3, 2015
Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?Pascal Richette, Augustin Latourte, Aline FrazierNature Reviews. Rheumatology|April 3, 2013
Biologic agents in osteoarthritis: hopes and disappointmentsXavier Chevalier, Florent Eymard, Pascal RichetteNature Reviews. Rheumatology|October 30, 2020
Emerging pharmaceutical therapies for osteoarthritisAugustin Latourte, Margreet Kloppenburg, Pascal RichetteKidney International|September 8, 2020
A cross-sectional study of 502 patients found a diffuse hyperechoic kidney medulla pattern in patients with severe goutThomas Bardin, Quang D Nguyen, Khoy M Tran, et al.Nature Reviews. Rheumatology|August 11, 2017
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)Nicola Dalbeth, Thomas Bardin, Michael Doherty, et al.European Journal of Physical and Rehabilitation Medicine|November 20, 2019
Shoulder adhesive capsulitis: diagnostic value of active and passive range of motion with volume of gleno-humeral capsule as a referenceEtienne James-Belin, Sandra Lasbleiz, Albert Haddad, et al.Joint Bone Spine|March 17, 2025
Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective studyThomas Bardin, Quang Dinh Nguyen, Valérie Bausson, et al.Arthritis|June 5, 2014
Treatment of nongout joint deposition diseases: an updateTristan Pascart, Pascal Richette, René-Marc FlipoSeminars in Arthritis and Rheumatism|February 20, 2022
The shrinking toe sign in goutThomas Bardin, Quang D Nguyen, Nghia L Hieu, et al.Rheumatology (Oxford, England)|September 11, 2021
Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndromeEmilie Chotard, Anne Blanchard, Agnès Ostertag, et al.Pageof 33